Trademark: 79302549
Status Date
Tuesday, September 6, 2022
Registration Number
6835721
Registration Date
Tuesday, September 6, 2022
Filing Date
Wednesday, November 11, 2020
Published for Opposition
Tuesday, June 21, 2022
5 Pharmaceutical preparations for neurological disease; pharmaceutical preparations for inflammatory diseases; pharmaceutical preparations for ocular and intraocular surgery; pharmaceutical preparations for rare autoimmune diseases in the nature of autoimmune lymphoproliferative syndrome, lupus, and multiple sclerosis; pharmaceutical products for the treatment of rare autoimmune diseases and disorders; pharmaceutical products for the prevention and treatment of rare genetic diseases affecting red blood cells; medicated ointments for treating dermatological conditions; antibiotic ointments; mentholated ointment for medical use; anti-inflammatory ointments; chemical reagents for purposes of medical diagnosis; diagnostic preparations for diagnosing inflammatory diseases; diagnostic radiopharmaceutical preparations; pharmaceutical and biological preparations for use in diagnosis, namely, for use as ultrasound and x-ray contrast reagents; antibiotics; anti-inflammatory preparations; anti-cancer preparations; biological preparations for the treatment of cancer; cardiovascular pharmaceutical preparations; dermatological pharmaceutical products; diagnostic preparations for medical or veterinary purposes; genetic identity tests comprised of reagents for medical purposes; human vaccine preparations; medicines for dental purposes; medicines for intestinal disorders; ophthalmic preparations; pharmaceutical agents affecting digestive organs; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; pharmaceutical agents affecting sensory organs; pharmaceutical preparations acting on the central nervous system; pharmaceutical agents for epidermis; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of musculo-skeletal disorders; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for treating skin disorders; pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of viral diseases; pharmaceutical products for treating respiratory diseases; pharmaceuticals for the treatment of erectile dysfunction; preparations for the treatment of asthma; tumor suppressing agents; vaccines; immunoassay reagents for medical use
42 Pharmaceutical research services; drug discovery services; medical research; pharmaceutical product evaluation; scientific investigations for medical purposes; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; consulting on the testing, inspection and research of medical products for quality control purposes; providing information on the testing, inspection and research of medical products for quality control purposes; industrial research in the fields of medicine, health and pharmacology; engineering services in the medical technology field
Jan 3, 2023
Final Decision Transaction Processed By Ib
Dec 9, 2022
Final Disposition Notice Sent To Ib
Dec 9, 2022
Final Disposition Processed
Dec 6, 2022
Final Disposition Notice Created, To Be Sent To Ib
Sep 6, 2022
Notice Of Registration Confirmation Emailed
Sep 6, 2022
Registered-Principal Register
Jul 11, 2022
Notification Of Possible Opposition - Processed By Ib
Jul 5, 2022
Notification Processed By Ib
Jun 22, 2022
Notification Of Possible Opposition Sent To Ib
Jun 22, 2022
Notification Of Possible Opposition Created, To Be Sent To Ib
Jun 21, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 21, 2022
Published For Opposition
Jun 8, 2022
Notification Of Possible Opposition Sent To Ib
Jun 8, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jun 1, 2022
Notification Of Notice Of Publication E-Mailed
May 13, 2022
Approved For Pub - Principal Register
Apr 28, 2022
Examiner's Amendment Entered
Apr 28, 2022
Notification Of Examiners Amendment E-Mailed
Apr 28, 2022
Examiners Amendment E-Mailed
Apr 28, 2022
Examiners Amendment -Written
Mar 31, 2022
Teas/Email Correspondence Entered
Mar 31, 2022
Correspondence Received In Law Office
Mar 31, 2022
Assigned To Lie
Mar 29, 2022
Teas Response To Office Action Received
Mar 29, 2022
Teas/Email Correspondence Entered
Mar 29, 2022
Correspondence Received In Law Office
Mar 29, 2022
Teas Response To Office Action Received
Oct 29, 2021
Notification Of Non-Final Action E-Mailed
Oct 29, 2021
Non-Final Action E-Mailed
Oct 29, 2021
Non-Final Action Written
Sep 30, 2021
Teas/Email Correspondence Entered
Sep 30, 2021
Correspondence Received In Law Office
Sep 30, 2021
Teas Response To Office Action Received
May 17, 2021
Refusal Processed By Ib
Apr 26, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Apr 26, 2021
Refusal Processed By Mpu
Apr 23, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Apr 22, 2021
Non-Final Action Written
Apr 21, 2021
Assigned To Examiner
Jan 26, 2021
Application Filing Receipt Mailed
Jan 22, 2021
New Application Office Supplied Data Entered In Tram
Jan 21, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
